Cover Image
Market Research Report
Product code 
936474

Asia-Pacific Submental Fat Treatment Market - Industry Trends and Forecast to 2027

Published: | Data Bridge Market Research Private Limited | 120 Pages | Delivery time: Inquiry

Price

Back to Top
Asia-Pacific Submental Fat Treatment Market - Industry Trends and Forecast to 2027
Published: April 1, 2020
Data Bridge Market Research Private Limited
Content info: 120 Pages
Delivery time: Inquiry
  • Description
  • Table of Contents
  • List of Tables

Asia Pacific submental fat treatment market is projected to register a CAGR of 14.1% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027

Market Segmentation

Asia Pacific Submental Fat Treatment Market, By Type (Invasive method and Minimally Invasive & Non Invasive Technology), , End User (Cosmetic Centers, Hospitals, Dermatology Clinics, Medical Spa And Others ), Distribution Channel (Direct Tender and Retail Sales), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest Of Asia-Pacific)-Industry Trends & Forecast to 2020

Some of the major factors contributing to the growth of the Asia Pacific submental fat treatment market are:

Increased reliability on liposuction procedure

Rising prevalence of obesity

Market Players

The key market players for Asia Pacific submental fat treatment market are listed below:

Allergan plc

Cynosure LLC

Lumenis

HIRONIC CO. LTD.

INMODE

BTL group of Companies

Alma Lasers

ENDYMED MEDICAL

Cutera

Laser Lipo Ltd.

Lumenis

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 TYPE LIFELINE CURVE
  • 2.8 DBMR MARKET POSITION GRID
  • 2.9 MARKET APPLICATION COVERAGE GRID
  • 2.10 VENDOR SHARE ANALYSIS
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 INDUSTRY INSIGHTS

  • 4.1 REIMBURSEMENT SCENARIO

5 MARKET OVERVIEW

  • 5.1 DRIVERS
    • 5.1.1 INCREASING AWARENESS FOR COSMETIC PROCEDURES AMONG PEOPLE
    • 5.1.2 RISING PREVALENCE OF OBESITY
    • 5.1.3 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
    • 5.1.4 INCREASED RELIABILITY ON LIPOSUCTION PROCEDURE
    • 5.1.5 AVAILABILITY OF ADVANCED AND USER FRIENDLY PRODUCTS
  • 5.2 RESTRAINTS
    • 5.2.1 HIGH COST OF PROCEDURES
    • 5.2.2 INCREASED RISKS ASSOCIATED WITH THE PROCEDURES
    • 5.2.3 STRINGENT REGULATIONS FOR APPROVAL OF PRODUCTS
  • 5.3 OPPORTUNITIES
    • 5.3.1 EVOLUTION IN LASER AND RF DEVICES
    • 5.3.2 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR COSMETIC PROCEDURES
    • 5.3.3 INTRODUCTION OF NOVEL NON- INVASIVE TECHNOLOGY
  • 5.4 CHALLENGES
    • 5.4.1 INCREASED RECOVERY TIME OF PROCEDURES
    • 5.4.2 REQUIREMENT OF MULTIPLE SESSIONS FOR GETTING MAXIMUM RESULTS

6 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY TYPE

  • 6.1 OVERVIEW
  • 6.2 MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY
    • 6.2.1 ULTRASOUND
    • 6.2.2 CRYOLIPOLYSIS
    • 6.2.3 RADIOFREQUENCY-ASSISTED CONTOURING
    • 6.2.4 LOW-LEVEL LASERS
    • 6.2.5 COMBINATION TREATMENT
    • 6.2.6 INJECTABLE ADIPOCYTOLYSIS
    • 6.2.7 OTHERS
  • 6.3 INVASIVE METHOD
    • 6.3.1 LIPOSUCTION
    • 6.3.2 SURGICAL REJUVENATION
    • 6.3.3 CHIN IMPLANT

7 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY END USER

  • 7.1 OVERVIEW
  • 7.2 COSMETIC CENTERS
  • 7.3 HOSPITALS
  • 7.4 DERMATOLOGY CLINICS
  • 7.5 MEDICAL SPA
  • 7.6 OTHERS

8 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL

  • 8.1 OVERVIEW
  • 8.2 DIRECT TENDER
  • 8.3 RETAIL SALES

9 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY GEOGRAPHY

  • 9.1 ASIA-PACIFIC
    • 9.1.1 JAPAN
    • 9.1.2 CHINA
    • 9.1.3 AUSTRALIA
    • 9.1.4 SOUTH KOREA
    • 9.1.5 SINGAPORE
    • 9.1.6 INDIA
    • 9.1.7 MALAYSIA
    • 9.1.8 THAILAND
    • 9.1.9 INDONESIA
    • 9.1.10 PHILIPPINES
    • 9.1.11 REST OF ASIA-PACIFIC

10 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, COMPANY LANDSCAPE

  • 10.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

11 SWOT & DATA BRIDGE MARKET RESEARCH ANALYSIS

  • 11.1 SWOT ANALYSIS
    • 11.1.1 STRENGTH: - SIGNIFICANT GROWTH OF SHARES IN MARKET FOCUSED SEGMENT
    • 11.1.2 STRENGTH: - FOCUSED ON AESTHETIC SOLUTIONS
    • 11.1.3 WEAKNESS: DEPENDENCE ON SUPPLIERS/ DISTRIBUTORS
    • 11.1.4 OPPORTUNITY: - STRATEGIC INITIATIVES FOR BUSINESS EXPANISION BY PRODUCT LAUNCH, ACQUISITION AND OTHERS
    • 11.1.5 THREAT: - CURRENCY FLUCTUATION
  • 11.2 DATA BRIDGE MARKET RESEARCH ANALYSIS

12 COMPANY PROFILE

  • 12.1 ALLERGAN
    • 12.1.1 COMPANY SNAPSHOT
    • 12.1.2 REVENUE ANALYSIS
    • 12.1.3 COMPANY SHARE ANALYSIS
    • 12.1.4 PRODUCT PORTFOLIO
    • 12.1.5 RECENT DEVELOPMENTS
  • 12.2 INMODE
    • 12.2.1 COMPANY SNAPSHOT
    • 12.2.2 REVENUE ANALYSIS
    • 12.2.3 COMPANY SHARE ANALYSIS
    • 12.2.4 PRODUCT PORTFOLIO
    • 12.2.5 RECENT DEVELOPMENT
  • 12.3 HIRONIC CO., LTD.
    • 12.3.1 COMPANY SNAPSHOT
    • 12.3.2 REVENUE ANALYSIS
    • 12.3.3 COMPANY SHARE ANALYSIS
    • 12.3.4 PRODUCT PORTFOLIO
    • 12.3.5 RECENT DEVELOPMENT
  • 12.4 CANDELA CORPORATION
    • 12.4.1 COMPANY SNAPSHOT
    • 12.4.2 COMPANY SHARE ANALYSIS
    • 12.4.3 PRODUCT PORTFOLIO
    • 12.4.4 RECENT DEVELOPMENT
  • 12.5 CYNOSURE LLC
    • 12.5.1 COMPANY SNAPSHOT
    • 12.5.2 PRODUCT PORTFOLIO
    • 12.5.3 RECENT DEVELOPMENTS
  • 12.6 BTL GROUP OF COMPANIES
    • 12.6.1 COMPANY SNAPSHOT
    • 12.6.2 SOLUTION PORTFOLIO
    • 12.6.3 RECENT DEVELOPMENTS
  • 12.7 ALMA LASERS (A SUBSIDIARY OF SISRAM MEDICAL LTD)
    • 12.7.1 COMPANY SNAPSHOT
    • 12.7.2 REVENUE ANALYSIS
    • 12.7.3 PRODUCT PORTFOLIO
    • 12.7.4 RECENT DEVELOPMENTS
  • 12.8 ENDYMED MEDICAL
    • 12.8.1 COMPANY SNAPSHOT
    • 12.8.2 REVENUE ANALYSIS
    • 12.8.3 PRODUCT PORTFOLIO
    • 12.8.4 RECENT DEVELOPMENT
  • 12.9 CUTERA
    • 12.9.1 COMPANY SNAPSHOT
    • 12.9.2 REVENUE ANALYSIS
    • 12.9.3 PRODUCT PORTFOLIO
    • 12.9.4 RECENT DEVELOPMENT
  • 12.10 ALASTIN SKINCARE, INC.
    • 12.10.1 COMPANY SNAPSHOT
    • 12.10.2 PRODUCT PORTFOLIO
    • 12.10.3 RECENT DEVELOPMENTS
  • 12.11 ERCHONIA CORPORATION
    • 12.11.1 COMPANY SNAPSHOT
    • 12.11.2 PRODUCT PORTFOLIO
    • 12.11.3 RECENT DEVELOPMENT
  • 12.12 LASER LIPO LTD.
    • 12.12.1 COMPANY SNAPSHOT
    • 12.12.2 PRODUCT PORTFOLIO
    • 12.12.3 RECENT DEVELOPMENT
  • 12.13 LUMENIS
    • 12.13.1 COMPANY SNAPSHOT
    • 12.13.2 PRODUCT PORTFOLIO
    • 12.13.3 RECENT DEVELOPMENT
  • 12.14 SOLTA MEDICAL
    • 12.14.1 COMPANY SNAPSHOT
    • 12.14.2 BRAND PORTFOLIO
    • 12.14.3 RECENT DEVELOPMENT
  • 12.15 THERMIGEN, LLC.
    • 12.15.1 COMPANY SNAPSHOT
    • 12.15.2 PRODUCT PORTFOLIO
    • 12.15.3 RECENT DEVELOPMENT

13 QUESTIONNAIRE

14 CONCLUSION

15 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 NUMBER OF SURGICAL AND NON SURGICAL AESTHETIC PROCEDURES IN DIFFERENT COUNTRIES
  • TABLE 2 AVERAGE COST OF LIPOSUCTION ACROSS THE U.S.
  • TABLE 3 AVERAGE COSTS OF CHIN AUGMENTATION ACROSS THE U.S.
  • TABLE 4 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 5 ASIA-PACIFIC MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 6 ASIA-PACIFIC MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 7 ASIA-PACIFIC INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 8 ASIA-PACIFIC INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 9 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 10 ASIA-PACIFIC COSMETIC CENTERS IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 11 ASIA-PACIFIC HOSPITALS IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 12 ASIA-PACIFIC DERMATOLOGY CLINICS IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13 ASIA-PACIFIC MEDICAL SPA IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 14 ASIA-PACIFIC OTHERS IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 15 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 16 ASIA-PACIFIC DIRECT TENDER IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17 ASIA-PACIFIC RETAIL SALES IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 18 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 19 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 20 ASIA-PACIFIC MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 21 ASIA-PACIFIC INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 22 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 23 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 24 JAPAN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 25 JAPAN MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 26 JAPAN INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 27 JAPAN SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 28 JAPAN SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 29 CHINA SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 30 CHINA MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 31 CHINA INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 32 CHINA SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 33 CHINA SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 34 AUSTRALIA SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 35 AUSTRALIA MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 36 AUSTRALIA INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 37 AUSTRALIA SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 38 AUSTRALIA SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 39 SOUTH KOREA SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 40 SOUTH KOREA MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 41 SOUTH KOREA INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 42 SOUTH KOREA SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 43 SOUTH KOREA SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 44 SINGAPORE SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 45 SINGAPORE MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 46 SINGAPORE INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 47 SINGAPORE SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 48 SINGAPORE SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 49 INDIA SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 50 INDIA MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 51 INDIA INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 52 INDIA SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 53 INDIA SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 54 MALAYSIA SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 55 MALAYSIA MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 56 MALAYSIA INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 57 MALAYSIA SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 58 MALAYSIA SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 59 THAILAND SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 60 THAILAND MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 61 THAILAND INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 62 THAILAND SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 63 THAILAND SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 64 INDONESIA SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 65 INDONESIA MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 66 INDONESIA INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 67 INDONESIA SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 68 INDONESIA SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 69 PHILIPPINES SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 70 PHILIPPINES MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 71 PHILIPPINES INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 72 PHILIPPINES SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 73 PHILIPPINES SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 74 REST OF ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: SEGMENTATION
  • FIGURE 2 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: DATA TRIANGULATION
  • FIGURE 3 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: DROC ANALYSIS
  • FIGURE 4 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 ASIA-PACIFIC SUBMENTAL FAT TREATMENTMARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: MARKET APPLICATION COVERAGE GRID
  • FIGURE 9 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 10 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: SEGMENTATION
  • FIGURE 11 GROWING FOCUS ON AESTHETICS AND EXPANSION OF TARGET DEMOGRAPHICS ARE EXPECTED TO DRIVE THE ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 12 MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET IN 2020 & 2027
  • FIGURE 13 ASIA-PACIFIC IS THE MAXIMUM GROWING REGION FOR SUBMENTAL FAT TREATMENT MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 14 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET
  • FIGURE 15 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY TYPE, 2019
  • FIGURE 16 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY TYPE, 2019-2027 (USD MILLION)
  • FIGURE 17 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY TYPE, CAGR (2020-2027)
  • FIGURE 18 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY TYPE, LIFELINE CURVE
  • FIGURE 19 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY END USER, 2019
  • FIGURE 20 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY END USER, 2019-2027 (USD MILLION)
  • FIGURE 21 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY END USER, CAGR (2020-2027)
  • FIGURE 22 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 23 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2019
  • FIGURE 24 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
  • FIGURE 25 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027)
  • FIGURE 26 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 27 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: SNAPSHOT (2019)
  • FIGURE 28 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019)
  • FIGURE 29 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 30 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 31 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY TYPE (2020-2027)
  • FIGURE 32 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: COMPANY SHARE 2019 (%)